149231-54-9

Basic information

• Product Name: 6-CHLORO-3-INDOLYL ACETATE
• Synonyms: Ethanone, 1-(6-chloro-3-hydroxy-1H-indol-1-yl)-;1-(5-chloro-3-hydroxy-1H-indol-1-yl)ethanone;6-Chloro-3-indoxyl-1-acetate
• CAS NO: 149231-54-9
• Molecular Formula: C10H8ClNO2
• Molecular Weight: 209.63
• Mol File: 149231-54-9.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-CHLORO-3-INDOLYL ACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-CHLORO-3-INDOLYL ACETATE(149231-54-9)
• EPA Substance Registry System: 6-CHLORO-3-INDOLYL ACETATE(149231-54-9)

Safety Data

• Hazardous Substances Data: 149231-54-9(Hazardous Substances Data)

Usage

Chemical compound

6-CHLORO-3-INDOLYL ACETATE

Structure

6-chlorinated indole ring attached to an acetate group

Usage

Reagent in organic synthesis, particularly in preparation of indole derivatives

Properties

Potential anti-inflammatory and anti-cancer properties

Applications

Inhibition of certain cancer cell growth, reduction of inflammation in animal models

Research

Used in study of plant growth and development, mimics action of plant hormone auxin

Upstream product

• 108761-33-7 6-chloro-3-acetoxy-1-acetylindole 

Relevant articles and documents

N-ARYLSULFONYL-3-AMINOALKOXYINDOLES

The present invention describes substituted 3-Aminoalkoxyindoles, compounds of the general formula (I), its stereoisomers, its radioisotopes, its geometric forms, its N-oxides, its polymorphs, its pharmaceutically acceptable salts, its pharmaceutically acceptable solvates, its useful bio-active metabolites and any suitable combination of the above. The invention also discloses the processes for preparing such compounds of the general formula (I), its stereoisomers, its radioisotopes, its geometric forms, its N-oxides, its polymorphs, its pharmaceutically acceptable salts, its pharmaceutically acceptable solvates, its useful bio-active metabolites and also includes any suitable combination of the above. Further described are various methods of administering these compounds of general formula (I), i.e. pharmaceutically acceptable dosage forms, their composition and their use in either therapy or diagnosis.

N-ARYLALKYL-3-AMINOALKOXYINDOLES AND THEIR USE AS 5-HT LIGANDS

The present invention describes substituted 3-Aminoalkoxyindoles, as compounds of the general formula (I), its stereoisomers, its radioisotopes, its geometric forms, its N-oxides, its polymorphs, its pharmaceutically acceptable salts, its pharmaceutically acceptable solvates, its useful bioactive metabolites and any suitable combination of the above. The invention also discloses the processes for preparing such compounds of the general formula (I), its stereoisomers, its radioisotopes, its geometric forms, its N-oxides, its polymorphs, its pharmaceutically acceptable salts, its pharmaceutically acceptable solvates, its useful bio-active metabolites and also includes any suitable combination of the above. Further described are various methods of administering these compounds of general formula (I), i.e. pharmaceutically acceptable dosage forms, their composition and their use in either therapy or diagnosis.